Oppenheimer Asset Management »

Abivax SA F shares owned by Oppenheimer Asset Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Oppenheimer Asset Management from 13F filings

Historical chart of Oppenheimer Asset Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Oppenheimer Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Oppenheimer Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $263k 3.1k 84.90

More positions owned by Oppenheimer Asset Management

Microsoft Corporation (MSFT)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Chevron Corporation (CVX)
Broadcom (AVGO)
Citigroup Com New (C)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Oracle Corporation (ORCL)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Oppenheimer Asset Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F